These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1590507)

  • 1. Neuroleptic malignant syndrome induced by low-dose haloperidol.
    Aisen PS; Lawlor BA
    Am J Psychiatry; 1992 Jun; 149(6):844. PubMed ID: 1590507
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome in Alzheimer's disease.
    Serby M
    J Am Geriatr Soc; 1986 Dec; 34(12):895-6. PubMed ID: 3782704
    [No Abstract]   [Full Text] [Related]  

  • 3. NMS and haloperidol.
    Velamoor VR
    Can J Psychiatry; 1991 Dec; 36(10):764. PubMed ID: 1819264
    [No Abstract]   [Full Text] [Related]  

  • 4. Crossover reaction between haloperidol and amoxapine for NMS.
    Otani K; Mihara K; Okada M; Kaneko S; Fukushima Y
    Br J Psychiatry; 1991 Dec; 159():889. PubMed ID: 1790471
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol in neuroleptic malignant syndrome.
    Shalev A; Ursano RJ
    Am J Psychiatry; 1988 May; 145(5):653-4. PubMed ID: 3358478
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome in the intensive care unit.
    Sing RF; Branas CC; Marino PL
    J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
    Hermesh H; Huberman M; Radvan H; Kott E
    J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome following BMT.
    Onose M; Kawanishi C; Onishi H; Yamada T; Itoh M; Kosaka K; Taguchi J; Fujisawa S; Kanamori H
    Bone Marrow Transplant; 2002 May; 29(9):803-4. PubMed ID: 12040481
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome induced by a single injection of haloperidol.
    Konikoff F; Kuritzky A; Jerushalmi Y; Theodor E
    Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1228-9. PubMed ID: 6437496
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hypomania following neuroleptic malignant syndrome.
    Steadman P
    Biol Psychiatry; 1992 Jul; 32(1):104-5. PubMed ID: 1391291
    [No Abstract]   [Full Text] [Related]  

  • 11. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined neuroleptic malignant syndrome and the central anticholinergic syndrome.
    Bennett DA
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):711. PubMed ID: 2213055
    [No Abstract]   [Full Text] [Related]  

  • 13. Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
    Legras A; Hurel D; Dabrowski G; Grenet D; Graveleau P; Loirat P
    Am J Med; 1988 Dec; 85(6):875-8. PubMed ID: 2904226
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neuroleptic malignant syndrome.
    O'Brien PJ
    Am J Psychiatry; 1987 Oct; 144(10):1371. PubMed ID: 2889381
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for neuroleptic malignant syndrome.
    Akpaffiong MJ
    J Natl Med Assoc; 1992 Sep; 84(9):800-2. PubMed ID: 1404479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome and preexisting brain damage.
    Lazarus A
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):185-7. PubMed ID: 1627980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fever caused by neuroleptics].
    Ottervanger JP; Gerbrandy-Colijn A; Stricker BH
    Ned Tijdschr Geneeskd; 1992 Nov; 136(46):2285-7. PubMed ID: 1461294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.
    Ryken TC; Merrell AN
    West J Med; 1989 Sep; 151(3):326-8. PubMed ID: 2588570
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant neuroleptic syndrome linked to haloperidol].
    Espino García A; Madrid Valls M; Mur Garcés R; Nadal Braqué N
    Aten Primaria; 2001 May; 27(9):677. PubMed ID: 11412563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.